Two Sigma Advisers
PGEN icon

Two Sigma Advisers’s Precigen PGEN Stock Holding History

Two Sigma Advisers’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-73,100
Closed -$306K – 1565
2025
Q4 		$306K Sell
73,100
-4,800
-6% -$18.6K ﹤0.01% 1979
2025
Q3 		$256K Sell
77,900
-5,700
-7% -$16.1K ﹤0.01% 2052
2025
Q2 		$119K Buy
83,600
+1,900
+2% +$2.7K ﹤0.01% 2190
2025
Q1 		$122K Sell
81,700
-10,900
-12% -$17.2K ﹤0.01% 2217
2024
Q4 		$104K Sell
92,600
-4,200
-4% -$3.58K ﹤0.01% 2216
2024
Q3 		$91.7K Sell
96,800
-14,900
-13% -$18.8K ﹤0.01% 2174
2024
Q2 		$176K Buy
111,700
+11,700
+12% +$17K ﹤0.01% 2242
2024
Q1 		$145K Sell
100,000
-600
-0.6% -$862 ﹤0.01% 2268
2023
Q4 		$135K Sell
100,600
-5,600
-5% -$6.58K ﹤0.01% 2291
2023
Q3 		$151K Sell
106,200
-50,800
-32% -$72K ﹤0.01% 2147
2023
Q2 		$181K Sell
157,000
-16,400
-9% -$19.4K ﹤0.01% 2117
2023
Q1 		$184K Sell
173,400
-168,311
-49% -$243K ﹤0.01% 2283
2022
Q4 		$519K Sell
341,711
-45,600
-12% -$78.4K ﹤0.01% 1862
2022
Q3 		$821K Sell
387,311
-52,600
-12% -$111K ﹤0.01% 1626
2022
Q2 		$589K Sell
439,911
-120,700
-22% -$179K ﹤0.01% 1844
2022
Q1 		$1.18M Buy
560,611
+242,400
+76% +$590K ﹤0.01% 1546
2021
Q4 		$1.18M Buy
318,211
+59,700
+23% +$257K ﹤0.01% 1479
2021
Q3 		$1.29M Sell
258,511
-120,500
-32% -$694K ﹤0.01% 1492
2021
Q2 		$2.47M Sell
379,011
-232,000
-38% -$1.62M 0.01% 1195
2021
Q1 		$4.21M Buy
611,011
+388,400
+174% +$3.28M 0.01% 921
2020
Q4 		$2.27M Buy
222,611
+31,000
+16% +$201K 0.01% 1191
2020
Q3 		$671K Buy
191,611
+14,500
+8% +$68.8K ﹤0.01% 1686
2020
Q2 		$884K Buy
177,111
+83,800
+90% +$285K ﹤0.01% 1636
2020
Q1 		$317K Buy
93,311
+32,000
+52% +$138K ﹤0.01% 1992
2019
Q4 		$336K Buy
+61,311
New +$345K ﹤0.01% 2025
2018
Q1 		– Sell
-10,800
Closed -$124K – 2393
2017
Q4 		$124K Buy
+10,800
New +$161K ﹤0.01% 2134
2015
Q2 		– Sell
-4,918
Closed -$213K – 2026
2015
Q1 		$213K Buy
+4,918
New +$177K ﹤0.01% 1715

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Two Sigma Advisers's PGEN Position: Q1 2026 in Review

Two Sigma Advisers sold out of Precigen (PGEN) in Q1 2026, closing a stake of 73,100 shares — an estimated $306K sold.

Two Sigma Advisers first reported a position in PGEN in Q1 2015 and held it in 27 quarters. The position peaked at $4.21M in Q1 2021. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Two Sigma Advisers reported no remaining Precigen position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 73,100 Precigen shares in Q1 2026, an estimated $306K.
  • Two Sigma Advisers first reported a position in Precigen in Q1 2015 and held it in 27 quarters.
  • Two Sigma Advisers's Precigen position peaked at $4.21M in Q1 2021.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.